Increased afterload induces pathological cardiac hypertrophy: a new in vitro model.
Increased afterload induces pathological cardiac hypertrophy: a new in vitro model.
复制标题
DOI:
10.1007/s00395-012-0307-z
复制
发表时间:
2012-11
影响因子:
9.5
通讯作者:
Eschenhagen T
中科院分区:
文献类型:
--
作者:
Hirt MN;Sörensen NA;Bartholdt LM;Boeddinghaus J;Schaaf S;Eder A;Vollert I;Stöhr A;Schulze T;Witten A;Stoll M;Hansen A;Eschenhagen T
Increased afterload results in ‘pathological’ cardiac hypertrophy, the most important risk factor for the development of heart failure. Current in vitro models fall short in deciphering the mechanisms of hypertrophy induced by afterload enhancement. The aim of this study was to develop an experimental model that allows investigating the impact of afterload enhancement (AE) on work-performing heart muscles in vitro. Fibrin-based engineered heart tissue (EHT) was cast between two hollow elastic silicone posts in a 24-well cell culture format. After 2 weeks, the posts were reinforced with metal braces, which markedly increased afterload of the spontaneously beating EHTs. Serum-free, triiodothyronine-, and hydrocortisone-supplemented medium conditions were established to prevent undefined serum effects. Control EHTs were handled identically without reinforcement. Endothelin-1 (ET-1)- or phenylephrine (PE)-stimulated EHTs served as positive control for hypertrophy. Cardiomyocytes in EHTs enlarged by 28.4 % under AE and to a similar extent by ET-1- or PE-stimulation (40.6 or 23.6 %), as determined by dystrophin staining. Cardiomyocyte hypertrophy was accompanied by activation of the fetal gene program, increased glucose consumption, and increased mRNA levels and extracellular deposition of collagen-1. Importantly, afterload-enhanced EHTs exhibited reduced contractile force and impaired diastolic relaxation directly after release of the metal braces. These deleterious effects of afterload enhancement were preventable by endothelin-A, but not endothelin-B receptor blockade. Sustained afterload enhancement of EHTs alone is sufficient to induce pathological cardiac remodeling with reduced contractile function and increased glucose consumption. The model will be useful to investigate novel therapeutic approaches in a simple and fast manner. The online version of this article (doi:10.1007/s00395-012-0307-z) contains supplementary material, which is available to authorized users.
登录
查看更多内容
影响因子:
37.8
作者:
Koegler, Harald;Schott, Peter;Hasenfuss, Gerd
通讯作者:
Hasenfuss, Gerd
影响因子:
20.1
作者:
Lee JH;Gao C;Peng G;Greer C;Ren S;Wang Y;Xiao X
通讯作者:
Xiao X
影响因子:
9.5
作者:
Miller CL;Cai Y;Oikawa M;Thomas T;Dostmann WR;Zaccolo M;Fujiwara K;Yan C
通讯作者:
Yan C
影响因子:
120.7
作者:
Levy, D;Larson, MG;Ho, KKL
通讯作者:
Ho, KKL
影响因子:
20.1
作者:
Kinugawa, K;Yonekura, K;Simpson, PC
通讯作者:
Simpson, PC